CN Patent

CN112245412B — 一种吸入用乙酰半胱氨酸溶液及其制备方法与应用

Assigned to Shanxi Guorun Pharmaceutical Co ltd · Expires 2023-04-07 · 3y expired

What this patent protects

本发明公开了一种吸入用乙酰半胱氨酸溶液及其制备方法与应用，属于医药制剂技术领域。所述吸入用乙酰半胱氨酸溶液中除了主药乙酰半胱氨酸、pH调节剂外不含其它辅料，且其制备过程中采用主药乙酰半胱氨酸对制备系统进行预处理，而不使用其它与处方无关的辅料，不仅整个生产环境洁净度级别高，还采用无菌灌装避免了后期的高温灭菌，故成品相较现有技术生产的吸入用乙酰半胱氨酸溶液杂质少、安全性和稳定性高，适于市面推广与应用。

USPTO Abstract

本发明公开了一种吸入用乙酰半胱氨酸溶液及其制备方法与应用，属于医药制剂技术领域。所述吸入用乙酰半胱氨酸溶液中除了主药乙酰半胱氨酸、pH调节剂外不含其它辅料，且其制备过程中采用主药乙酰半胱氨酸对制备系统进行预处理，而不使用其它与处方无关的辅料，不仅整个生产环境洁净度级别高，还采用无菌灌装避免了后期的高温灭菌，故成品相较现有技术生产的吸入用乙酰半胱氨酸溶液杂质少、安全性和稳定性高，适于市面推广与应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN112245412B
Jurisdiction
CN
Classification
—
Expires
2023-04-07
Drug substance claim
No
Drug product claim
No
Assignee
Shanxi Guorun Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.